|
Comparison of P-cadherin expression in different breast cancer subtypes |
|||
| IBC |
Non-IBC |
p-value |
|
|
|
|||
| n(%) |
n(%) |
||
|
|
|||
| Basal cases (ER-,ERBB2-) |
18/19(95%) |
35/51(69%) |
0.05 |
| ERBB2-overexpressing cases |
9/13(69%) |
32/47(68%) |
NS |
| Luminal cases (ER+, PR+) |
14/17(82%) |
84/197(43%) |
<0.01 |
Ben Hamida et al. BMC Cancer 2008 8:28 doi:10.1186/1471-2407-8-28 |
|||